Meeting Banner
Abstract #3819

A National Clinical Research MRI Quality Assurance and Quality Control Survey by NCITA

Penny L Hubbard Cristinacce1,2, Damien J McHugh1,2, Matthew R Orton2,3, Arnold JV Benjamin2,4, Ross A Little1,2, James P. B. O'Connor1,2,3, and Maite Jauregui-Osoro2,5
1The University of Manchester, Manchester, United Kingdom, 2National Cancer Imaging Translational Accelerator (NCITA), CRUK, United Kingdom, 3Institute of Cancer Research, Sutton, United Kingdom, 4University of Cambridge, Cambridge, United Kingdom, 5Imperial College London, London, United Kingdom

National Cancer Imaging Translational Accelerator (NCITA) ran a survey on quality assurance (QA) and quality control (QC) procedures for human MRI scanners and associated equipment at research institutions across the UK. The survey was conducted by the NCITA QA/QC Unit, which is developing an MRI core lab to facilitate the validation and standardisation of quality-assured imaging biomarkers from first-in-human studies to the assessment of multicentre reproducibility. The results showed institutions emphasise the earlier part of the QA/QC pipeline (i.e. scanner maintenance and data acquisition QA), with fewer institutions performing comprehensive QC on acquired/analysed data or any software quality management.

This abstract and the presentation materials are available to members only; a login is required.

Join Here